These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 30532706)

  • 1. Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.
    Feng W; Ao H; Peng C
    Front Pharmacol; 2018; 9():1354. PubMed ID: 30532706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.
    Zhang B; Yue R; Chen Y; Yang M; Huang X; Shui J; Peng Y; Chin J
    Evid Based Complement Alternat Med; 2019; 2019():2634898. PubMed ID: 30906411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, a new frontier to understand traditional Chinese medicines.
    Feng W; Ao H; Peng C; Yan D
    Pharmacol Res; 2019 Apr; 142():176-191. PubMed ID: 30818043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
    Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
    van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
    J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between herbal medicines and gut microbiota in metabolic diseases.
    Wang L; Gou X; Ding Y; Liu J; Wang Y; Wang Y; Zhang J; Du L; Peng W; Fan G
    Front Pharmacol; 2023; 14():1105405. PubMed ID: 37033634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids.
    Yamamura R; Nakamura K; Kitada N; Aizawa T; Shimizu Y; Nakamura K; Ayabe T; Kimura T; Tamakoshi A
    Biosci Microbiota Food Health; 2020; 39(1):11-17. PubMed ID: 32010539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
    Lyu M; Wang YF; Fan GW; Wang XY; Xu SY; Zhu Y
    Front Microbiol; 2017; 8():2146. PubMed ID: 29167659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids.
    Liu CS; Liang X; Wei XH; Jin Z; Chen FL; Tang QF; Tan XM
    Front Microbiol; 2019; 10():825. PubMed ID: 31057525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
    Yao Y; Liu Y; Xu Q; Mao L
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.
    Yue B; Zong G; Tao R; Wei Z; Lu Y
    Phytother Res; 2022 Nov; 36(11):4125-4138. PubMed ID: 36100366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
    Silva YP; Bernardi A; Frozza RL
    Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
    Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
    Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between the gut Microbiota and herbal medicines.
    An X; Bao Q; Di S; Zhao Y; Zhao S; Zhang H; Lian F; Tong X
    Biomed Pharmacother; 2019 Oct; 118():109252. PubMed ID: 31545247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
    Guo B; Zhang J; Zhang W; Chen F; Liu B
    Crit Rev Food Sci Nutr; 2023 Oct; ():1-22. PubMed ID: 37897083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Gut Microbiota and Metabolomics for Chinese Medicine Research: Opportunities and Challenges.
    Feng WW; Liu J; Cheng H; Peng C
    Chin J Integr Med; 2022 Nov; 28(11):1032-1039. PubMed ID: 34755290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
    Li Y; Ji X; Wu H; Li X; Zhang H; Tang D
    J Ethnopharmacol; 2021 Oct; 278():114207. PubMed ID: 34000365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of short-chain fatty acids in microbiota-gut-brain communication.
    Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
    Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
    Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.